Literature DB >> 22639297

BMP-2 and TGF-β3 do not prevent spontaneous degeneration in rabbit disc explants but induce ossification of the annulus fibrosus.

Daniel Haschtmann1, Stephen J Ferguson, Jivko V Stoyanov.   

Abstract

INTRODUCTION: Different approaches for disc regeneration are currently under investigation. Beside gene therapy and tissue engineering techniques, the application of growth and differentiation factors own promising potential. Studies using reduced intervertebral disc models, such as cell or tissue fragment cultures, have limited validity and show controversial results depending on the employed experimental model. Therefore, the goal of the current study was to investigate the effect of BMP-2 and TGF-β3 on intervertebral disc degeneration using an in vitro full-organ disc/endplate culture system.
MATERIALS AND METHODS: Intervertebral rabbit disc explants were cultured in the presence of 1 μg/ml BMP-2 or TGF-β3 for 21 days in DMEM/F12 media. Nucleus and annulus were analyzed for gene expression of collagen type I and II (Col I/II), aggrecan, collagenases (MMP-1/MMP-13) with RT-qPCR, histological changes with bone and proteoglycan-specific staining (von Kossa, toluidine blue) and differences in cellularity (DNA) and proteoglycan content (alcian blue binding assay).
RESULTS: The results demonstrate that disc proteoglycan concentration decreased with time in the TGF-β3 and BMP-2 groups. In the annulus fibrosus (AF), TGF-β3 and BMP-2 resulted in an up-regulation of Col I and type II, and of aggrecan gene expression. In contrast, MMP genes were inhibited. In the nucleus, the growth factors decreased gene expression of aggrecan and spontaneous Col I up-regulation was inhibited by TGF-β3, whereas expression of Col II was decreased with BMP-2. There was no effect on expression of MMP-1 and MMP-13 for most sampling points. However, TGF-β3 and BMP-2 induced ossification of the AF was demonstrated by histology.
CONCLUSION: It can be concluded that both growth factors, at the tested concentrations, may not be suitable to regenerate the whole intervertebral disc organ but they are interesting candidates for being injected alone or in combination into a painful intervertebral disc to induce osseous fusion (spondylodesis).

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22639297      PMCID: PMC3459107          DOI: 10.1007/s00586-012-2371-3

Source DB:  PubMed          Journal:  Eur Spine J        ISSN: 0940-6719            Impact factor:   3.134


  67 in total

1.  Changes in mRNA and protein levels of proteoglycans of the anulus fibrosus and nucleus pulposus during intervertebral disc degeneration.

Authors:  Gabriella Cs-Szabo; Deborah Ragasa-San Juan; Vani Turumella; Koichi Masuda; Eugene J-M A Thonar; Howard S An
Journal:  Spine (Phila Pa 1976)       Date:  2002-10-15       Impact factor: 3.468

2.  In vivo growth factor treatment of degenerated intervertebral discs.

Authors:  Andrew J L Walsh; David S Bradford; Jeffrey C Lotz
Journal:  Spine (Phila Pa 1976)       Date:  2004-01-15       Impact factor: 3.468

3.  The use of recombinant human bone morphogenetic protein 2 (rhBMP-2) to promote spinal fusion in a nonhuman primate anterior interbody fusion model.

Authors:  B P Hecht; J S Fischgrund; H N Herkowitz; L Penman; J M Toth; A Shirkhoda
Journal:  Spine (Phila Pa 1976)       Date:  1999-04-01       Impact factor: 3.468

4.  Quantitation of proteoglycans as glycosaminoglycans in biological fluids using an alcian blue dot blot analysis.

Authors:  S Björnsson
Journal:  Anal Biochem       Date:  1998-02-15       Impact factor: 3.365

Review 5.  Biology of intervertebral disc aging and degeneration: involvement of the extracellular matrix.

Authors:  Peter J Roughley
Journal:  Spine (Phila Pa 1976)       Date:  2004-12-01       Impact factor: 3.468

6.  Growth factors in intervertebral disc homeostasis.

Authors:  Harris Pratsinis; Dimitris Kletsas
Journal:  Connect Tissue Res       Date:  2008       Impact factor: 3.417

7.  Perioperative complications of recombinant human bone morphogenetic protein-2 on an absorbable collagen sponge versus iliac crest bone graft for posterior cervical arthrodesis.

Authors:  Charles H Crawford; Leah Y Carreon; Mark D McGinnis; Mitchell J Campbell; Steven D Glassman
Journal:  Spine (Phila Pa 1976)       Date:  2009-06-01       Impact factor: 3.468

8.  The effect of bone morphogenetic protein-2 on rat intervertebral disc cells in vitro.

Authors:  S Tim Yoon; Keun Su Kim; Jun Li; Jin Soo Park; Tomoyuki Akamaru; William A Elmer; William C Hutton
Journal:  Spine (Phila Pa 1976)       Date:  2003-08-15       Impact factor: 3.468

Review 9.  Role of transforming growth factor-beta superfamily signaling pathways in human disease.

Authors:  Kelly J Gordon; Gerard C Blobe
Journal:  Biochim Biophys Acta       Date:  2008-02-11

10.  Recombinant human bone morphogenetic protein-2-induced radiculitis in elective minimally invasive transforaminal lumbar interbody fusions: a series review.

Authors:  Stefan A Mindea; Patrick Shih; John K Song
Journal:  Spine (Phila Pa 1976)       Date:  2009-06-15       Impact factor: 3.468

View more
  17 in total

Review 1.  Molecular basis of intervertebral disc degeneration and herniations: what are the important translational questions?

Authors:  Tiffany Kadow; Gwendolyn Sowa; Nam Vo; James D Kang
Journal:  Clin Orthop Relat Res       Date:  2015-06       Impact factor: 4.176

2.  Is Osteogenic Differentiation of Human Nucleus Pulposus Cells a Possibility for Biological Spinal Fusion?

Authors:  Sharon J Brown; Sarah A Turner; Birender S Balain; Neil T Davidson; Sally Roberts
Journal:  Cartilage       Date:  2018-01-23       Impact factor: 4.634

3.  Developments in intervertebral disc disease research: pathophysiology, mechanobiology, and therapeutics.

Authors:  Kathryn T Weber; Timothy D Jacobsen; Robert Maidhof; Justin Virojanapa; Chris Overby; Ona Bloom; Shaheda Quraishi; Mitchell Levine; Nadeen O Chahine
Journal:  Curr Rev Musculoskelet Med       Date:  2015-03

Review 4.  Mechanisms and clinical implications of intervertebral disc calcification.

Authors:  Uruj Zehra; Marianna Tryfonidou; James C Iatridis; Svenja Illien-Jünger; Fackson Mwale; Dino Samartzis
Journal:  Nat Rev Rheumatol       Date:  2022-05-09       Impact factor: 32.286

Review 5.  Ageing in the musculoskeletal system.

Authors:  Sally Roberts; Pauline Colombier; Aneka Sowman; Claire Mennan; Jan H D Rölfing; Jérôme Guicheux; James R Edwards
Journal:  Acta Orthop       Date:  2016-10-17       Impact factor: 3.717

6.  Synergistic effects of overexpression of BMP‑2 and TGF‑β3 on osteogenic differentiation of bone marrow mesenchymal stem cells.

Authors:  Yilin Wang; Tian He; Jie Liu; Hongzhi Liu; Lugang Zhou; Wei Hao; Yujie Sun; Xin Wang
Journal:  Mol Med Rep       Date:  2016-11-22       Impact factor: 2.952

Review 7.  Molecular therapy for disk degeneration and pain.

Authors:  Fackson Mwale
Journal:  Global Spine J       Date:  2013-07-12

8.  Mohawk promotes the maintenance and regeneration of the outer annulus fibrosus of intervertebral discs.

Authors:  Ryo Nakamichi; Yoshiaki Ito; Masafumi Inui; Naoko Onizuka; Tomohiro Kayama; Kensuke Kataoka; Hidetsugu Suzuki; Masaki Mori; Masayo Inagawa; Shizuko Ichinose; Martin K Lotz; Daisuke Sakai; Koichi Masuda; Toshifumi Ozaki; Hiroshi Asahara
Journal:  Nat Commun       Date:  2016-08-16       Impact factor: 14.919

9.  Differences in calcification and osteogenic potential of herniated discs according to the severity of degeneration based on Pfirrmann grade: a cross-sectional study.

Authors:  Jia Shao; Miao Yu; Liang Jiang; Feng Wei; Fengliang Wu; Zhongjun Liu; Xiaoguang Liu
Journal:  BMC Musculoskelet Disord       Date:  2016-04-29       Impact factor: 2.362

10.  Sequencing and bioinformatics analysis of the differentially expressed genes in herniated discs with or without calcification.

Authors:  Jia Shao; Miao Yu; Liang Jiang; Fengliang Wu; Xiaoguang Liu
Journal:  Int J Mol Med       Date:  2016-12-07       Impact factor: 4.101

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.